Summary
The development of thrombosis involves 4 main factors: the vessel wall, the formed elements of the blood, blood coagulation, and blood flow. In venous thrombosis the dominant mechanism is blood coagulation. In arterial thrombosis, however, the major part in both the initiation and growth of thrombi is played by the platelets.
In selecting drugs which inhibit platelet function it is helpful to know which of the platelet reactions that contribute to thrombus formation can be inhibited by various agents. Platelets adhere to the damaged vessel wall, collagen being probably the most important constituent involved. They are then stimulated to release the contents of their storage granules. Release-inducing agents promote the discharge of adenosine diphosphate (ADP) which causes platelets in the vicinity to swell to a more spherical shape, extend pseudopods and adhere to each other. Platelet aggregation is reversible, and a number of drugs have been shown to be capable of inhibiting platelet function at various stages, both in vitro and in vivo.
Adrenaline, noradrenaline, oestrogens and nicotine enhance aggregation. Drugs which inhibit platelet function include the non-steroidal anti-inflammatory drugs, the pyrimido-pyrimidines (e.g. dipyridamole), hydroxychloroquine, clofibrate, and dextran.
In this review the effects of drugs which inhibit platelet function are outlined and the extent to which they can be used to influence the course of thromboembolic disease in man is discussed. It is suggested that combinations of anti-platelet drugs with anticoagulants could prove clinically useful.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abrams, W.B. and Solomon, H.M.: The human platelet as a pharmacologic model for the adrenergic neuron. Clinical Pharmacology and Therapeutics 10: 702–709 (1969).
Abramson, H.A.: The electrophoresis of the blood platelets of the horse with reference to their origin and to thrombus formation. Journal of Experimental Medicine 47: 677–681 (1928).
Acheson, J.; Danta, G. and Hutchinson, E.C.: Controlled trial of dipyridamole in cerebral vascular disease. British Medical Journal 1: 614–615 (1969).
Ahtee, L. and Saarnivaara, L.: The effect of drugs upon the uptake of 5-hydroxytryptamine and metaraminol by human platelets. Journal of Pharmacy and Pharmacology 23: 495–501 (1971).
Aledort, L.M. and Niemetz, J.: Dissociation of platelet aggregation from clot retraction, potassium loss, and adenosine triphosphatase activity. Proceedings of the Society for Experimental Biology and Medicine 128: 658–661 (1968).
Al-Mondhiry, H.; Marcus, A.J. and Spaet, T.H.: On the mechanism of platelet function inhibition by acetylsalicylic acid. Proceedings of the Society for Experimental Biology and Medicine 133: 632–636 (1970).
Amer, M.S. and Marquis, N.R.: The effect of prostaglandins, epinephrine and aspirin on cyclic AMP phosphodiesterase activity of human blood platelets and their aggregation. In Ramwell and Pharriss Prostaglandins in Cellular Biology, p. 93–109 (Plenum Publishing Corporation, New York 1972).
Amir, J. and Krauss, S.: Treatment of thrombotic thrombocytopenic purpura with antiplatelet drugs. Blood 42: 27–33 (1973).
Anderson, M.C. and Shields, T.W.: An evaluation of factors which influence the incidence and extent of venous thrombosis. Surgery 51: 347–350 (1962).
Anderson, W.A.D.: In Pathology, Vol. 1, p. 506 (C.V. Mosby, St. Louis 1966).
Andrassy, K.; Ritz, E.; Schoeffner, W.; Hahn, G. and Walter, K.: The influence of acetylsalicylic acid on platelet adhesiveness and thrombotic fistula complications in hemodialysed patients. Klinische Wochenschrift 49: 166–167(1971).
Ardlie, N.G.: Studies on the mechanism of adenosine diphosphate-induced platelet aggregation. Thesis, McMaster University, Hamilton (1971).
Ardlie, N.G.; Glew, G.; Schultz, B.G. and Schwartz, C.J.: Inhibition and reversal of platelet aggregation by methylxanthines. Thrombosis et Diathesis Haemorrhagica 18: 670–673 (1967).
Ardlie, N.G.; Glew, G. and Schwartz, C.J.: Influence of catecholamines on nucleotide-induced platelet aggregation. Nature 212: 415–417 (1966).
Arfors, K.E.: Drugs, platelets and injury to the microcirculation. Canadian Medical Association Journal 108: 456–457 (1973).
Arfors, K.-E.; Hint, H.C.; Dhall, D.P. and Matheson, N.A.: Counteraction of platelet activity at sites of laser-induced endothelial trauma. British Medical Journal 4: 430–431 (1968).
Arrants, J.E. and Hairston, P.: Use of Persantine in preventing thromboembolism following valve replacement. The American Surgeon 38: 432–435 (1972).
Arthur, J.B. et al.: Five year study by a group of physicians of the Newcastle upon Tyne Region: Trial of clofibrate in the treatment of ischaemic heart disease. British Medical Journal 4: 161–115 (1971).
Ashford, T.P. and Freiman, D.G.: Platelet aggregation at sites of minimal endothelial injury. American Journal of Pathology 53: 599–607 (1968).
Ashwin, J.G.: The effect of drugs on experimental thrombogenesis; in MacMillin and Mustard Anticoagulants and Fibrinolysins p. 117–127 (Macmillan, Toronto 1961).
Atac, M.; Spagnuolo, M. and Zucker, M.B.: Long-term inhibition of platelet functions by aspirin. Proceedings of the Society for Experimental Biology and Medicine 133: 1331–1333(1970).
Ball, G.; Brereton, G.G.; Fulwood, M.; Ireland, D.M. and Yates, P.: Effect of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3′:5′ — cyclic monophosphate. Biochemical Journal 120: 709–718 (1970).
Baroldi, G.: Acute coronary occlusion as a cause of myocardial infarct and sudden coronary heart death. American Journal of Cardiology 16: 859–880 (1965).
Baumgartner, H.R.: The subendothelial surface and thrombosis. Proceedings of the Fourth International Congress on Thrombosis and Haemostasis, Vienna, p. 42 (1973).
Baumgartner, H.R. and Born, G.V.R.: Effects of 5-hydroxytryptamine on platelet aggregation. Nature 275: 137–141 (1968).
Baumgartner, H.R. and Born, G.V.R.: The relation between the 5-hydroxytryptamine content and aggregation of rabbit platelets. Journal of Physiology (London) 207: 397–408 (1969).
Behnke, O.: Electron microscopic observations on the membrane systems of the rat blood platelet. Anatomical Record 158: 121–137 (1967).
Bennett, P.N.; Dhall, D.P.; McKenzie, F.N. and Matheson, N.A.: Effects of dextran infusion on the adhesiveness of human platelets. Lancet 2: 1001–1003 (1966).
Bergström, S.: Prostaglandins: Members of a new hormonal system. Science 157: 382–391 (1967).
Berman, H.J. and Fulton, G.P.: Platelets in the peripheral circulation; in: Johnson, Monto, Rebuck and Horn Blood Platelets. Henry Ford Hospital International Symposium, Boston, p. 7–20 (Little, Brown and Company, Boston 1961).
Best, C.H.; Cowan, C. and Maclean, D.L.: Heparin and the formation of white thrombi. Journal of Physiology (London) 92: 20–31 (1938).
Besterman, E.M.M. and Gillett, M.P.T.: Heparin effects on irreversible platelet aggregation. Lancet 2: 282–283 (1972).
Bettex-Galland, M. and Lüscher, E.F.: Studies on the metabolism of human blood platelets in relation to clot retraction. Thrombosis et Diathesis Haemorrhagica 4: 178–195 (1960).
Bicher, H.I. and Beemer, A.: Prevention by an anti-adhesive drug of thrombosis caused by blood cell aggregation. Angiology 21: 431–441 (1971).
Biggs, R.; Denson, K.W.E.; Akman, N.; Borrett, R. and Hadden, M.: Antithrombin III, antifactor Xa and heparin. Brit. J. Haemat. 19: 283–305 (1970).
Birnstingl, M.A.; Brinson, K. and Chakrabarti, B.K.: The effect of short-term exposure to carbon monoxide on platelet stickiness. British Journal of Surgery 58: 837–839 (1971).
Blakely, J.A. and Gent, M.: Platelets, drugs and longevity in a geriatric population; in Hirsh, Cade, Gallus and Schonbaum Platelets, Drugs and Thrombosis (Karger, New York 1974).
Born, G.V.R.: Observations on the change in shape of blood platelets brought about by adenosine diphosphate. Journal of Physiology (London) 209: 487–511 (1970).
Born, C.V.R. and Cross, M.J.: The aggregation of blood platelets. Journal of Physiology 168: 178–195 (1963a).
Born, G. V.R. and Cross, M.J.: Effect of adenosine diphosphate on the concentration of platelets in circulating blood. Nature 797: 974–976 (1963b).
Born, G.V.R.; Juengjaroen, K. and Michal, F.: Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues. British Journal of Pharmacology 44: 117–139 (1972).
Bom, G.V.R. and Mills, D.C.B.: Potentiation of the inhibitory effect of adenosine on platelet aggregation by drugs that prevent its uptake. Journal of Physiology (London) 202: 41P-42P (1969).
Boston Collaborative Drug Surveillance Group: Regular aspirin intake and acute myocardial infarction. British Medical Journal 1: 440–443 (1974).
Brånemark, P.-I. and Ekholm, R.: Adherence of blood cells to vascular endothelium. Blut 16: 274–288 (1968).
Brinson, K.: Effect of aminophylline on blood platelet reactions. Atherosclerosis 16: 233–239 (1972).
Brisman, R.; Parks, L.C. and Haller, J.A.: Dextran prophylaxis in surgery. Annals of Surgery 174: 137–141 (1971).
Brown, C.H.; Natelson, E.A.; Bradshaw, M.W.; Williams, T.W. and Alfrey, C.P.: The hemostatic defect produced by carbenicillin (CBN). Blood 42: 995 (1973).
Browse, N.L. and Hall, J.H.: Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis. Lancet 2: 718–721 (1969).
Bucher, H.W. and Stucki, P.: The effect of various beta-receptor blocking agents on platelet aggregation. Experientia 25: 280–282 (1969).
Bull, B.S. and Zucker, M.B.: Changes in platelet volume produced by temperature, metabolic inhibitors, and aggregating agents. Proceedings of the Society of Experimental Biology and Medicine 120: 296–301 (1965).
Burrows, L.; Haimon, M.; Glabman, S.; Wong, D.; Bauer, J.; Aledort, L.; Severin, C. and Kark, A.C.: The obliterative vascular transplant rejection phenomenon. The role of platelet aggregation. Hague Conference on Transplantation (1970).
Bygdeman, S.: Prevention and therapy of thromboembolic complications with dextran. Progress in Surgery (Basel) 7: 114–139 (1969).
Bygdeman, S.; Eliasson, R. and Gullbring, B.: Effects of dextran infusion on the adenosine diphosphate induced adhesiveness and the spreading capacity of human blood platelets. Thrombosis et Diathesis Haemorrhagica 15: 451–456 (1966).
Bygdeman, S. and Johnsen, Ø: Studies on the effect of adrenergic blocking drugs on catecholamine-induced platelet aggregation and uptake of noradrenaline and 5-hydroxytryptamine. Acta Physiology Scandanavian 75: 129–138 (1969).
Caen, J.P. and Levy-Toledano, S.: Interaction between platelets and von Willebrand factor provides a new scheme for primary hemostatis. Nature New Biology 244: 159–160 (1973).
Caren, R. and Corbo, L.: Depression of plasma lipid fractions and inhibition of platelet aggregation by action of glucagon. Metabolism 20: 1057–1064 (1971).
Carlson, L.A.; Irion, E. and Orö, L.: Effect of infusion of prostaglandin E1 on the aggregation of blood platelets in man. life Sciences 7: 85–90 (1968).
Carson, P.; McDonald, L.; Pickard, S.; Pilkington, T.; Davies, B. and Love, F.: Effect of Atromid on platelet stickiness. Journal of Atherosclerosis Research 3: 619–622 (1963).
Carter, A.E.; Eban, R. and Perrett, R.D.: Prevention of post-operative deep venous thrombosis and pulmonary embolism. British Medical Journal 1: 312–314 (1971).
Cazenave, J.-P; Guccione, M.A.; Packham, M.A. and Mustard, J.F.: Two phases of ristocetin-induced platelet aggregation. Proceedings of the 16th Annual Meeting, American Society of Hematology, Chicago, p. 163 (1973b).
Cazenave, J.-P.; Packham, M.A.; Guccione, M.A. and Mustard, J.F.: Effects of penicillin G on platelet aggregation, release, and adherence to collagen. Proceedings of the Society for Experimental Biology in Medicine 142: 159–166 (1973a).
Cazenave, J.-P.; Packham, M.A.; Guccione, M.A. and Mustard, J.F.: Inhibition of platelet adherence to a collagen-coated surface by non-steroidal anti-inflammatory drugs, pyrimido-pyrimidine and tricyclic compounds, and lidocaine. Journal of Laboratory and Clinical Medicine 83: 797–806 (1974a).
Cazenave, J.-P; Packham, M.A.; Guccione, M.A. and Mustard, J.F.: Inhibition of platelet adherence to a collagen-coated surface by agents that inhibit platelet functions (Unpublished observations, 1974b).
Cazenave, J.-P.; Packham, M.A. and Mustard, J. F.: Platelet adherence to a collagen-coated surface. Proceedings of the Third Congress of the International Society on Thrombosis and Haemostasis, Washington, D.C., p. 178 (1972).
Chakrabarti, R.; Evans, J.F. and Feamley, G.R.: Effects on platelet stickiness and fibrinolysis of phenformin combined with ethyoestrenol or stanozolol. Lancet 1: 591–593 (1970).
Chakrabarti, R.; Fearnley, G.R. and Evans, J.F: Effects of clofibrate on fibrinolysis, platelet stickiness, plasma-fibrinogen, and serum-cholesterol. Lancet 2: 1007–1009 (1968).
Chandra, Sekhar, H: Prostaglandins and platelet function. Thrombosis et Diathesis Haemorrhagica 42 (Suppl.): 305–314 (1970).
Chinitz, J.L; Kim, K.E.; Onesti, G. and Swartz, C.: Pathophysiology and prevention of dextran-40-induced anuria. J. Lab. clin Med. 77: 76–87 (1971).
Claes, G.: The effect of platelet deaggregating substances on renal allograft rejection in sensitized dogs. Acta Chirurgica Scandinavica 139: 127–130 (1973).
Clarkson, A.R.; MacDonald, M.K.; Cash, J.D. and Robson, J.S.: Modification by drugs of urinary fibrin/ fibrinogen degradation products in glomular nephritis. British Medical Journal 3: 255–260 (1972).
Clawson, C.C. and White, J.G.: Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. American Journal of Pathology 65: 367–380 (1971).
Cayton, S. and Cross, M.J.: The aggregation of blood platelets by catecholamines and by thrombin. Journal of Physiology (London) 169: 82P (1963).
Cobb, S.; Anderson, F. and Bauer, W.: Length of life and cause of death in rheumatoid arthritis. New England Journal of Medicine 249: 553–556 (1953).
Cronberg, S.; Robertson, B.; Nilsson, I.M. and Nilehn, M.-E.: Suppressive effect of dextran on platelet adhesiveness. Thrombosis et Diathesis Haemorrhagica 76: 384–394 (1966).
Crunkhorn, P. and Willis, A.L.: Cutaneous reactions to intradermal prostaglandins. British Journal of Pharmacology 41: 49–56 (1971).
Cucuianu, M.P.: Nishizawa, E.E. and Mustard, J.F.: Effect of pyrimido-pyrimidine compounds on platelet function. Journal of Laboratory and Clinical Medicine 77: 958–974 (1971).
Damus, P.S.; Hicks, M. and Rosenberg, R.D.: Anticoagulant action of heparin. Nature 246: 355–357 (1973).
Danese, C.A. and Haimov, M.: Inhibition of experimental arterial thrombosis in dogs with platelet deaggregating agents. Surgery 70: 927–934 (1971).
Danese, C.A.; Voleti, C.D. and Weiss, H.J.: Protection by aspirin against experimentally induced arterial thrombosis in dogs. Thrombosis et Diathesis Haemorrhagica 25: 288–296 (1971).
Davey, M.G. and Lander, H.: Effect of adenosine diphosphate on circulating platelets in man. Nature 201: 1037–1039 (1964).
Davey, M.G. and Lüscher, E.F.: Biochemical aspects of platelet function and hemostasis. Seminars in Hematology 5: 5–17 (1968a).
Davey, M.G. and Lüscher, E.F.: Release reactions of human platelets induced by thrombin and other agents. Biochimica et Biophysica Acta 165: 490–506 (1968b).
Davis, J.W. and Phillips, P.E.: The effect of ethanol on human platelet aggregation in vitro. Atherosclerosis 11: 473–477 (1970).
Day, H.J. and Holmsen, H.: Concepts of the blood platelet release reaction. Series Haematologica IV 1: 3–27 (1971).
Day, H.J. and Solum, N.O.: Fibrinogen associated with subcellular platelet particles. Scandinavian Journal of Haematology 10: 136–143 (1973).
De Clerck, F.: Effect of lidoflazine (R 7904) on human platelet function in vitro. Thrombosis et Diathesis Haemorrhagica 28: 228–236 (1972).
De Clerck, F.F. and Reneman, R.S.: Effect of lidoflazine (R 7904) on uptake and release of serotonin by human platelets in vitro. Archives of Pharmacology (Naunyn-Schmiedeberg’s) 278: 261–269 (1973).
de Gaetano, G.; Bottecchia, D. and Vermylen, J.: Retraction of reptilase-clots in the presence of agents inducing or inhibiting the platelet adhesion-aggregation reaction. Thrombosis Research 2: 71–84 (1973).
de Gaetano, G; Donati, M.E. and Vermylen, J.: Some effects of indomethacin on platelet function, blood coagulation and fibrinolysis. International Journal of Clinical Pharmacology 5: 196–199(1971).
de Gaetano, G.; Franco, R.; Donati, M.B.; Bonaccorsi, A. and Garattini, S.: Mechanical recording of reptilase-clot retraction: effect of adenosine-5′-diphosphate and prostaglandin E1. Thrombosis Research 4: 189–192 (1974).
Dhall, D.P. and Matheson, N.A.: In vitro clumping of human platelets by dextran. Thrombosis et Diathesis Haemorrhagica 19: 70–76 (1968).
Didisheim, P.: Animal models useful in the study of thrombosis and antithrombotic agents; in Spaet Progress in Hemostasis and Thrombosis, Vol. 1, p. 165–197 (Grune and Stratton, New York 1972).
Didisheim, P. and Owen, C.A.: Effect of dipyridamole (Persantin) and its derivates on thrombosis and platelet function. Thrombosis et Diathesis Haemorrhagica 42 (Suppl.): 267–275 (1970).
Didisheim, P.; Sturm, R.E. and Owen, C.A.: Experiments on thrombosis and its prevention. Sherbrooke Symposium on Blood Coagulation (Sherbrooke, Quebec 1970).
Donati, M.B.; de Gaetano, G. and Vermylen, J.: Human platelet clumping by bovine fibrinogen. The role of platelets in haemostasis and thrombosis. Symposium with International Participation, Prague, abstract 15 (1971).
Donati, M.B.; de Gaetano, G. and Vermylen, J.: Evidence that bovine factor VIII, not bovine fibrinogen, aggregates human platelets. Thrombosis Research 2: 97–104 (1973).
Doyle, J.T.; Danber, T.R.; Kannel, W.B.; Kinch, S.H. and Kahn, H.A.: The relationship of cigarette smoking to coronary heart disease; the second report of the combined experience of the Albany, New York and Framingham, Massachusetts, studies. Journal of the American Medical Association 190: 886–890 (1964).
Drill, V.A.: Oral contraceptives and thromboembolic disease I. Prospective and retrospective studies. Journal of the American Medical Association 219: 583–592 (1972).
Dugdale, M. and Masi, A. T.: Hormonal contraception and thromboembolic disease: Effects of the oral contraceptives on hemostatic mechanisms. A review of the literature. Journal of Chronic Diseases 23: 775–790 (1971).
Dyken, M.L.; Campbell, R.L.; Muller, J.; Feuer, H.; Horner, T.; King, R.; Kolar, O.; Solow, E. and Jones, F.H.: Effect of aspirin on experimentally induced arterial thrombosis during the healing phase. Stroke 4: 387–389 (1973a).
Dyken, M.L.; Kolar, O.J. and Jones, F.H: Differences in the occurrence of carotid transient ischemic attacks associated with anti-platelet aggregation therapy. Stroke 4: 732–736 (1973b).
Eastham, R.D. and Griffiths, E.P.: Reduction of platelet adhesiveness and prolongation of coagulation-time of activated plasma by glyceryl guiacolate. Lancet 1: 795–796(1966).
Eika, C: Platelet refractory state induced by heparin. Scandinavian Journal of Haematology 9: 665–672 (1972a).
Eika, C.: The platelet aggregating effect of eight commercial heparins Scandinavian Journal of Haematology 9: 480–482 (1972b).
Eliasson, R. and Bygdeman, S.: Effect of dipyridamole and two pyrimido-pyrimidine derivatives on the kinetics of human platelet aggregation and on platelet adhesiveness. Scandinavian Journal of Clinical Investigation 24: 145–151 (1969).
Elkeles, R.S.; Hampton, J.R.; Harrison, M.J.G. and Mitchell, J.R.A.: Prostaglandin E1 and human platelets. Lancet 2: 111 (1969).
Ekleles, R.S.; Hampton, J.R.; Honour, A.J; Mitchell, J.R.A. and Prichard, J.S.: Effect of a pyrimidopyrimidine compound on platelet behaviour in vitro and in vivo. Lancet 2: 751–754 (1968a).
Ekleles, R.S.; Hampton, J.R. and Mitchell, J.R.A.: Effect of oestrogens on human platelet behaviour. Lancet 2: 315–318 (1968b)
Elwood, P.C.; Cochrane, A.L.; Burr, M.L.; Sweetnam, P.M.; Williams, G.; Welsby, E.; Hughes, S.J. and Renton, R.: A randomized controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. British Medical Journal 1: 436–440 (1974).
Emmons, P.R.; Hampton, J.R.; Harrison, M.J.G.; Honour, A.J. and Mitchell, J.R.A.: Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. British Medical Journal 2: 468–472 (1967).
Emmons, P.R.; Harrison, M.J.G.; Honour, A.J. and Mitchell, J.R.A.: Effect of a pyrimido-pyrimidine derivative on thrombus formation in the rabbit. Nature 208: 255–257 (1965a).
Emmons, P.R.; Harrison, M.J.G.; Honour, A.J. and Mitchell, J.R.A.: Effect of dipyridamole on human platelet behaviour. Lancet 2: 603–606 (1965b).
Erdös, E.G.: Effect of nonsteroidal anti-inflammatory drugs in endotoxin shock. Biochemical Pharmacology p. 283–291 (Pergamon Press, Oxford 1968).
Evans, G.: Effect of platelet-suppressive agents on the incidence of amaurosis fugax and transient cerebral ischemia; in McDowell and Brennan Cerebral Vascular Diseases, p. 297–300 (Grune and Stratton, New York 1973).
Evans, G. and Mustard, J.F.: Inhibition of the plateletsurface reaction in endotoxin shock and the generalized Shwartzman reaction. Journal of Clinical Investigation 47: 31a (1968).
Evans, G.; Packham, M.A.; Nishizawa, E.E. Mustard, J.F. and Murphy, E.A.: The effect of acetylsalicylic acid on platelet function. Journal of Experimental Medicine 128: 877–894 (1968).
Evensen, S.A. and Elgjo, R.F.: Antibody-induced platelet injury: Its potency as a trigger of intravascular clotting. Scandinavian Journal of Haematology 9: 61–72(1972).
Evensen, S.A.; Elgjo, R.F.; Jörgensen, L. and Husby, G.: Glomerular fibrin thrombi induced by antigen-antibody reactions: Protection by extreme thrombocytopenia. Microvascular Research 4: 117–131 (1972).
Fearnley, G.R.; Chakrabarti, R. and Evans, J.F: Effect of ethyl oestrenol combined with phenformin or with metformin on platelet stickiness and serum cholesterol in patients with occlusive vascular disease. Lancet 2: 1004–1007 (1968).
Ferreira, S.H. and Vane, JR.: Prostaglandins: Their disappearance from and release into the circulation. Nature 216: 868–873 (1967).
Fleming, J.S.; Bierwagen, M.E.; Campbell, J.A.L. and King, S.P.: The effect of a new anti-inflammatory agent (5-cyclohexylindan-l-carboxylic acid (BL-2365) on platelet aggregation. Archives Internationales de Pharmacodynamie et de Therapie 199: 164–171(1972).
Fleming, J.S.; Bierwagen, M.E.; Losada, M.; Campbell, J.A.L.; King, S.P. and Pindell, M.H.: The effects of the anti-inflammatory agents on platelet aggregation, in vitro and in vivo. Archives Internationales de Pharmacodynamie et de Thérapie 186: 120–128 (1970).
Fleming, A. and Fish, E.W.: Influence of penicillin on the coagulation of blood with especial reference to certain dental operations. British Medical Journal 2: 242–243 (1947).
Forbes, CD.; McNichol, G.P. and Douglas, A.S.: Action of a pyrimido-pyrimidine compound on platelet behaviour in vitro. Brit. med. J. 2: 483–485 (1969).
Forbes, C.D. and Prentice, C.R.M.: Aggregation of human platelets by purified porcine and bovine antihaemophilic factor. Nature New Biology 241: 149–150 (1973).
French, J.E.: Endothelial structure and function; in Jones Evolution of the Atherosclerotic Plaque, p. 15–28 (University of Chicago Press, Chicago 1963).
Fulton, G.P; Akers, R.P. and Lutz, B.R.: White thromboemboli and vascular fragility in hamster cheek pouch after anticoagulants. Blood 8: 140–152 (1953).
Gadd, R.E.A.; Clayman, S. and Hébert, D.: The effect of several diuretics on adenosine-diphosphate induced platelet aggregation in vitro. Experientia 27: 1339–1340 (1971).
Gallus, A.S.; Hirsh, J.; Tuttle, R.J.; Trebilcock, R.; O’Brien, S.E; Carroll, J.J.; Minden, J.H. and Hudecki, S.M.: Small subcutaneous doses of heparin in prevention of venous thrombosis. New England Journal of Medicine 288: 545–551 (1973).
Gangarosa, E.J.; Johnson, T.R. and Ramos, H.S.: Ristocetin-induced thrombocytopenia: Site and mechanism of action. American Medical Association Archives of Internal Medicine 105: 107/83-113/89 (1960).
Gaynor, E.: Hormonally altered thrombogenicity in rabbit iliac arteries. Blood 42: 979 (1973).
Gent, A.E.; Brook, C.G.D.; Foley, T.H. and Miller, T.N.: Dipyridamole: A controlled trial of its effect in acute myocardial infarction. British Medical Journal 4: 366–368 (1968).
Genton, E; Steele, PP.; Weily, H.S.; Archer, P.G. and Davies, D.H.: Value of platelet survival and irrelevance of platelet adhesion and aggregation as predictors of thrombosis. Proceedings of the Fourth International Congress on Thrombosis and Haemostasis, Vienna, p. 161 (1973).
Gilbert, J.B. and Mustard, J.F.: Some effects of Atromid on platelet economy and blood coagulation in man. Journal of Atherosclerosis Research 3: 623–633 (1963).
Giromini, M.; Bouvier, C.A.; Dami, R.; Denizot, M. and Jeannet, M.: Effect of dipyridamole and aspirin in thrombotic microangiopathy. British Medical Journal 1: 545–546 (1972).
Glynn, M.F.; Murphy, E.A. and Mustard, J.F.: Effect of clofibrate on platelet economy in man. Lancet 2: 447_448 (1967).
Goldman, B.; Aledort, L.M.; Puszkin, E.V. and Burrows, L.: Cyproheptadine, a new platelet deaggregating agent. Circulation 44 (Suppl. 2): 68 (1971).
Goldsmith, H.L.: The flow of model particles and blood cells and its relation to thrombogenesis; in Spaet Progress in Hemostasis and Thrombosis, Vol. 1, p. 97–139 (Grune and Stratton, New York 1972).
Gollub, S.; Schaefer, C. and Squitieri, A.: The bleeding tendency associated with plasma expanders. Surgery, Gynecology and Obstetrics 124: 1203–1211 (1967).
Griggs, T.R.; Cooper, H.A.; Webster, W.P.; Wagner, R.H. and Brinkhous, K.M.: Plasma aggregating factor (bovine) for human platelets: A marker for study of antihemophilic and von Willebrand factors. Proceedings of the National Academy of Science, USA 70: 2814–2818 (1973).
Gross, R.: Metabolic aspects of normal and pathological platelets; in Johnson, Monto, Rebuck and Horn Blood Platelets, p. 407–421 (Little, Brown and Company, Boston 1961).
Grøttum, K.A.: Platelet surface charge and aggregation. Effect of polyelectrolytes. Thrombosis et Diathesis Haemorrhagica 21: 450–461 (1969).
Gunning, A.J.; Pickering, G.W.; Robb-Smith, A.H.T. and Russell, R.R.: Mural thrombosis of the internal carotid artery and subsequent embolism. Quarterly Journal of Medicine 33: 155–195 (1964).
Haerem, J. W.: Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease. Atherosclerosis 15: 199–213 (1972).
Haft, J.I.; Gershengorn, K.; Kranz, P.D. and Oestreicher, R.: Protection against epinephrine-induced myocardial necrosis by drugs that inhibit platelet aggregation. American Journal of Cardiology 30: 838–843 (1972a).
Haft, J.I.; Kranz, P.D.; Albert, F.J. and Fani, K.: Intravascular platelet aggregation in the heart induced by norepinephrine — Microscopic studies. Circulation 46: 698–708 (1972b).
Haining, C.G.: Histamine release in rabbit blood by dextran and dextran sulphate. British Journal of Pharmacology 10: 87–94 (1955).
Hampton, J.R. and Mitchell, J.R.A.: Thrombosis; in Biggs Human Blood Coagulation, Haemostasis and Thrombosis, p. 476–496 (Blackwell Scientific Publications, Oxford 1972).
Hardisty, R.M. and Hutton, R.A.: Platelet aggregation and the availability of platelet factor 3. British Journal of Haematology 12: 764–776 (1966).
Harker, L.A. and Slichter, S.J.: Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. New England Journal of Medicine 283: 1302–1305 (1970).
Harker, LA. and Slichter, S.J.: Platelet and fibrinogen consumption in man. New England Journal of Medicine 287: 999–1005 (1972).
Harker, L.A. and Slichter, S.J.: Arterial thromboembolism — quantitation and prevention. Proceedings of the Fourth International Congress on Thrombosis and Haemostasis, Vienna, p. 170 (1973).
Harland, V.A. and Holburn, A.M.: Coronary thrombosis and myocardial infarction. Lancet 2: 1158–1160 (1966).
Harrison, M.J.G.; Marshall, J.; Meadows, J.C. and Russell, R.W.R.: Effect of aspirin in amaurosis fugax. Lancet 2: 743–744 (1971).
Haslam, R.J.: Role of adenosine diphosphate in the aggregation of human blood-platelets by thrombin and by fatty acids. Nature 202: 765–768 (1964).
Haslam, R.J.: Inhibition of blood platelet function by cytochalasins: Effects on thrombosthenin and on glucose metabolism. Biochemical Journal 127: 34P (1972).
Haslam, R.J.: Personal communication (1973).
Haslam, R.J. and McClenaghan, M.D.: Effects of collagen and of aspirin on the concentration of guanosine 3′, 5′-cyclic monophosphate in human blood platelets: Measurement by a prelabelling technique. Biochemical Journal 138: 317–320 (1974).
Haslam, R.J. and Rosson, G.M.: Aggregation of human blood platelets by vasopressin. American Journal of Physiology 223: 958–967 (1972).
Haslam, R.J. and Taylor, A.: Role of cyclic 3′, 5′-adenosine monophosphate in platelet aggregation; in Caen Platelet Aggregation, p.85–93 (Masson et Cie, Paris 1971).
Hassanein, A.A.; Turpie, A.G.G.; McNichol, G.P. and Douglas, A.S.: Effect of RA 233 on platelet function in vitro. Brit. med. J. I: 83–86 (1970).
Haut, J. and Cowan, D.H.: Effect of ethanol on human platelet function. Journal of Clinical Investigation 50: 44a (1971).
Havig, ø.: Pathogenesis of peripheral venous thrombosis. An autopsy study. Proceedings of the Fourth International Congress on Thrombosis and Haemostasis, Vienna, p. 275 (1973).
Hawkins, R.I.: Smoking, platelets and thrombosis. Nature 236: 450–452 (1972).
Heikinheimo, R. and Järvinen, K.: Acetylsalicylic acid and arteriosclerotic thromboembolic diseases in the aged. Journal of the American Geriatrics Society 19: 403–405 (1971).
Heisig, N.; Westermann, K.-W.; Stolterfoht, C.A. and Zaki, J.: Die Wirkung von Pyridinolcarbamat (Anginin) bei peripheren arteriellen Durchblutungsstörungen. Medizinische Klinik 65: 2289–2293 (1970).
Herrmann, R.G.: Effect of platelet aggregation inhibitors on the bleeding time. Canadian Medical Association Journal 108: 454–455 (1973).
Herrmann, R.G. and Frank, J.D.: Effect of adenosine derivatives and anti-histaminics on platelet aggregation. Proceedings of the Society for Experimental Biology and Medicine 123: 654–660 (1966).
Herrmann, R.G.; Marshall, W.S.; Crowe, V.G. and Frank, J.D.: Effect of a new anti-inflammatory drug, fenoprofen, on platelet aggregation and thrombus formation. Proceedings of the Society for Experimental Biology and Medicine 139: 548–552 (1972).
Hilden, M.; Amris, C.J. and Starup, J.: The haemostatic mechanism in oral contraception. Acta Obstetrica et Gynecologica Scandinavica 46: 562–571 (1967).
Hinshaw, L.B.; Solomon, LA.; Erdös, E.G.; Reins, D.A. and Gunter, B.J.: Effects of acetylsalicylic acid on the canine response to endotoxin. Journal of Pharmacology and Experimental Therapeutics 157: 665–671 (1967).
Hirsh, J.; Street, D; Cade, J.F. and Amy, H: Relation between bleeding time and platelet connective tissue reaction after aspirin. Blood 41: 369–377 (1973).
Holmsen, H.; Day, H.J. and Setkowsky, C.A.: Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline. Biochemical Journal 129: 67–82 (1972).
Holmsen, H.; Day, H.J. and Stormorken, H.: The blood platelets release reaction. Scandinavian Journal of Haematology 8 (Suppl.): 1–26 (1969).
Honour, A.J. and Ross-Russell, R.W.: Experimental platelet embolism. British Journal of Experimental Pathology 43: 350–362 (1962).
Horch, U.; Kadatz, R.; Kopitar, Z.; Ritschard, J. and Weisenberg, H.: Pharmacology of dipyridamole and its derivatives. Thrombosis et Diathesis Haemorrhagica 42 (Suppl.): 253–266 (1970).
Hougie, C.: Thromboembolism and oral contraceptives. American Heart Journal 85: 538–545 (1973).
Houlihan, R.B.: The adhesion of dog platelets to bacteria; in Morphologic Hematology. Blood (Special issue No. 1): 155–160 (1947).
Hovig, T.: Aggregation of rabbit blood platelets produced in vitro by saline ‘extract’ of tendons. Thrombosis et Diathesis Haemorrhagica 9: 248–263 (1963a).
Hovig, T.: Release of a platelet aggregating substance (adenosine diphosphate) from rabbit platelets induced by saline ’extract’ of tendons. Thrombosis et Diathesis Haemorrhagica 9: 264–278 (1963b).
Hovig, T.; Arfors, K.-E.; Bergqvist, D. and McKenzie, F.N.: Mechanism of the platelet response to laser-induced intravascular injury ultrastructural studies. Proceedings of the Third Congress of the International Society on Thrombosis and Haemostasis, Washington, D.C., p. 364 (1972).
Howard, M.A. and Firkin, B.G.: Ristocetin — a new tool in the investigation of platelet aggregation. Thrombosis et Diathesis Haemorrhagica 26: 362–369 (1971).
Howard, M.A.; Hutton, R.A. and Hardisty, R.M.: Hereditary giant platelet syndrome: A disorder of a new aspect of platelet function. British Medical Journal 1: 586–588 (1973a).
Howard, M.A.; Sowers, R.J. and Firkin, B.G.: Ristocetin: A means of differentiating von Willebrand’s disease into two groups. Blood 41: 687–690 (1973b).
Hugues, J.: Accolement des plaquettes aux structures conjonctives périvasculaires. Thrombosis et Diathesis Haemorrhagica 8: 241–255 (1962).
Ingerman, C.; Smith, J.B.; Kocsis, J.J. and Silver, M.J.: Arachidonic acid induces platelet aggregation and platelet prostaglandin formation (abstract). Federation Proceedings 32: 219 (1973).
Inman, W.H.W.; Vessey, M.P.; Westerholm, B. and Engelund, A.: Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. British Medical Journal 2: 203–209 (1970).
Irion, E. and Blombäck, M.: Prostaglandins in platelet aggregation. Scandinavian Journal of Clinical and Laboratory Investigation 24: 141–144 ( 1969).
Izuka, K. and Murata, K.: Inhibitory effects of human aortic and venous acid glycosaminoglycans on thrombus formatin. Atherosclerosis 16: 217–224 (1972).
Jamieson, G.A.; Urban, C.L. and Barber, A.J.: Enzymatic basis for platelet: Collagen adhesion as the primary step in haemostasis. Nature New Biology 234: 5–7 (1971).
Janssen, P.A.J.: Pharmacologie et effets cliniques de la lidoflazine; in Actualités Pharmacologiques 23 ième série, p. 135–161 (Masson et Cie, Paris, 1970).
Jaques, L.B.: Heparin from different sources. Lancet 2: 1262 (1972).
Jenkins, C.S.P.; Packham, M.A.; Guccione, M.A. and Mustard, J.F.: Modification of platelet adherence to protein-coated surfaces. Journal of Laboratory and Clinical Medicine 81: 280–290 (1973).
Jenkins, C.S.P.; Packham, M.A.; Kinlough-Rathbone, R.L. and Mustard, J.F: Interactions of polylysine with platelets. Blood 37: 395–412 (1971).
Jennings, E.R.; Owen, C.A.; Weiss, H.J.; Mustard, J.F. and Zucker, M.B.: Questions and answers: Is recent aspirin ingestion cause to defer platelet donor? Journal of the American Medical Association 217: 1872–1873 (1971).
Jerushalmy, Z.; Kohn, A. and De Vries, A.: Interaction of myxoviruses with human blood platlets in vitro. Proceedings of the Society for Experimental Biology and Medicine 106: 462–466 (1961).
Jevons, S. and Barton, P.G.: Biochemistry of blood platelets. Interaction of activated factor X with platelets. Biochemistry 10: 428–434 (1971).
Jobin, F. and Tremblay, F.: Platelet reactions and immune processes II. The inhibition of platelet aggregation by complement inhibitors. Thrombosis et Diathesia Haemorrhagica 22: 466–481 (1969).
Joist, J.H.; Lloyd, J.V. and Mustard, J.F: Availability of platelet factor 3 activity in suspensions of washed platelets. Proceedings of the Third Congress of the International Society on Thrombosis and Haemostasis, Washington, D.C., p. 210 (1972).
Jørgensen, L.; Haerem, J.W.; Chandler, A.B. and Borchgrevink, C.F.: The pathology of acute coronary death. Acta Anaesthesiologica Scandinavica 29 (Suppl.): 193–199(1968).
Jørgensen, L.; Haerem, J. W. and Moe, N.: Platelet thrombosis and nontraumatic injury in mouse aorta. Thrombosis et Diathesis Haemorrhagica 29: 470–489 (1973).
Jørgensen, L.; Rowsell, H.C.; Hovig, T.; Glynn, M.F. and Mustard, J.F.: Adenosine diphosphate-induced aggregation and myocardial infarction in swine. Laboratory Investigation 17: 616–644 (1967).
Kagan, A.: Information on thombosis as a cause of death, from studies promoted by the World Health Organization; in Sherry, Brinkhous, Genton and Stengle Thrombosis, p. 236–269 (National Academy of Sciences, Washington, D.C. 1969).
Kakkar, V.V.; Field, ES.; Nicolaides, A.N.; Flute, P.T.; Wessler, S. and Yin, E. T.: Low doses of heparin in prevention of deep-vein thrombosis. Lancet 2: 669–671 (1971).
Kampmann, J.; Hansen, J.M.; Siersboek-Nielsen, K. and Laursen, H: Effect of some drugs on penicillin half-life in blood. Clinical Pharmacology and Therapeutics 13: 516–519 (1972).
Kaneshiro, M.M.; Mielke, C.H.; Kasper, C.K. and Rapaport, S.I.: Bleeding time after aspirin in disorders of intrinsic clotting. New England Journal of Medicine 281: 1039–1042 (1969).
Kasper, C.K. and Rapaport, S.I.: Bleeding times and platelet aggregation after analgesics in hemophilia. Annals of Internal Medicine 77: 189–193 (1972).
Kincaid-Smith, P.: Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants. Lancet 2: 920–922 (1969).
Kinlough-Rathbone, R.L.; Packham, M.A. and Mustard, J.F.: The effect of glucose on adenosine diphosphate-induced platelet aggregation. J. Lab. clin. Med. 75: 780–787 (1970a).
Kinlough-Rathbone, R.L.; Packham, M.A. and Mustard, J.F.: The effect of prostaglandin E1 on platelet function in vitro and in vivo. British Journal of Haematology 19: 559–571 (1970b).
Kinlough-Rathbone, R.L.; Packham, M.A. and Mustard, J.F.: The effect of glucose on the platelet response to release-inducing stimuli. Journal of Laboratory and Clinical Medicine 80: 247–255 (1972).
Kloeze, J.: Influence of prostaglandins on platelet adhesiveness and platelet aggregation; in Bergström and Samuelsson Proceedings of 2nd Nobel Symposium, Stockholm, June 1966, p. 241–252 (Almqvist and Wiksell, Stockholm Interscience, New York 1967).
Kloeze, J.: Relationship between chemical structure and platelet-aggregation activity of prostaglandins. Bio-chimica et Biophysica Acta 187: 285–292 (1969).
Kobayashi, I. and Didisheim, P.: Effect of pyridinolcarbamate (PDC) on platelet aggregation in vitro and in vivo (abstract). Federation Proceedings 31: 818 (1972).
Kocsis, J.J.; Hemandovich, J.; Silver, M.J.; Smith, J.B. and Ingerman, C.: Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin. Prostaglandins 3: 141–144 (1973).
Kricheff, II.; Zucker, M.B.; Tschopp, T.B. and Kolodjiez, A.: Inhibition of thrombosis on vascular catheters in cats. Radiology 106: 49–51 (1973).
Kubisz, P. and Suranová, J.: On the mechanism by which bovine fibrinogen induces the release and availability reaction of human blood platelets. Thrombosis et Diathesis Haemorrhagica 29: 416–433 (1973).
Lalezari, P. and Spaet, T.H.: Antiheparin and hemagglutinating activities of polybrene. Journal of Laboratory and Clinical Medicine 57: 868–873 (1961).
Lemmer, B.; Wiethold, G.; Hellenbrecht, D.; Bak, I.J. and Grobecker, H.: Human blood platelets as cellular models for investigation of membrane active drugs; Beta-adrenergic blocking agents. Archives of Pharmacology (Naunyn-Schmiedeberg’s) 275: 299–313 (1972).
Levine, P.H.: An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation 48: 619–623 (1973).
Lindsay, RM.; Prentice, C.R.M.; Ferguson, D; Burton, J.A. and McNicol, G.P.: Reduction of thrombus formation on dialyser membranes by aspirin and RA 233. Lancet 2: 1287–1290 (1972).
Lurie, A.; Ogilvie, M.; Townsend, M.; Gold, C.; Meyers, A.M. and Goldberg, B.: Carbenicillin-induced coagulopathy. Lancet 1: 1114–1115 (1970).
Lüscher, E.F. and Bettex-Galland, M.: Thrombosthenin, the contractile protein of blood platelets. New facts and problems. Pathologie et Biologie 20 (Suppl.): 89–101 (1972).
Lyman, D.J.; Brash, J.L.; Chaikin, S.W.; Klein, K.G. and Carini, M.: The effect of chemical structure and surface properties of synthetic polymers on coagulation of blood II. Protein and platelet interaction with polymer surfaces. Transactions of the American Society for Artificial Internal Organs 14: 250–255 (1968).
McClure, P.D.; Casserly, J.G.; Monsier, C. and Crozier, D.: Carbenicillin-induced bleeding disorder. Lancet 2: 1307–1308 (1970).
MacDonald, A.; Busch, G.J.; Alexander, J.L.; Pheteplace, E.A.; Menzoian, J. and Murray, J.E.: Heparin and aspirin in the treatment of hyperacute rejection of renal allografts in presensitized dogs. Transplantation 9: 1–7 (1969).
McDonald, J.W.D. and Stuart, R.K.: Regulation of cyclic AMP levels and aggregation in human platelets by prostaglandin E1. Journal of Laboratory and Clinical Medicine 81: 838–849 (1973).
McDonald, J.W.D. and Stuart, R.K.: Interaction of prostaglandin E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: Evidence for a common prostaglandin receptor. Journal of Laboratory and Clinical Medicine 84: 111–121 (1974).
McDonald, L. and Edgill, M.: Action of heparin in ischaemic heart disease. Lancet 1: 844–847 (1961).
McDonald, T.P.; Woodard, D. and Cottrell, M.: Effect of nicotine on clot retraction of rat blood platelets. Pharmacology 9: 357–366 (1973).
McKay, D.G.: Progress in disseminated intravascular coagulation. California Medicine 111: 186–198 and 279–290 (1969).
McKay, D.G. and Margaretten, W.: Disseminated intravascular coagulation in virus diseases. Archives of Internal Medicine 120: 129–159 (1967).
MacMillan, D.C.: Secondary clumping effect in human citrated platelet-rich plasma produced by adenosine diphosphate and adrenaline. Nature 211: 140–144 (1966).
MacMillan, D.C.: Effect of salicylates on human platelets. Lancet 1: 1151 (1968).
Majerus, P.W. and Brodie, G.N.: The binding of phytohemagglutinins to human platelet plasma membranes. Journal of Biological Chemistry 247: 4253–4257 (1972).
Marcus, A.J.: Platelet function. New England Journal of Medicine 280: 1213–1220, 1278–1284, 1330–1335 (1969).
Margaretten, W. and McKay, D.G.: The requirement for platelets in the active Arthus reaction. American Journal of Pathology 64: 257–263 (1971).
Markwardt, F.; Barthel, W.; Glusa, E. and Hoffmann, A.: Untersuchungen über den Einfluss von Papaverin auf Reaktionen der Blutplättchen. Archives of Pharmacology (Naunyn-Schmiedeberg’s) 257: 420–431 (1967).
Marquis, N.R.; Vigdahl, R.L. and Tavormina, P.A.: Platelet aggregation I. Regulation by cyclic AMP and prostaglandin E1. Biochemical and Biophysical Research Communications 36: 965–972 (1969).
Mason, R.G.; Shermer, R.W. and Rodman, N.F: Reactions of blood with non biologic surfaces. American Journal of Pathology 69: 271–288 (1972).
Massini, P. and Lüscher, E.F.: The induction of the release reaction in human blood platelets by close cell contact. Thrombosis et Diathesis Haemorrhagica 25: 13–20 (1971).
Massini, P. and Lüscher, E.F.: On the mechanism by which cell contact induced the release reaction of blood platelets; The effect of cationic polymers. Thrombosis et Diathesis Haemorrhagica 27: 121–133 (1972).
Mathew, T.H.; Hogan, G.P.; Lewers, D.T.; Bauer, H.; Maher, J.F. and Schreiner, G.E.: Controlled double-blind trial of anti-platelet aggregating agents in vascular renal allograft rejection. Transplantation Proceedings 3: 901–904 (1971).
Mayer, J.E. and Hammond, G.L.: Dipyridamole and aspirin tested against an experimental model of thrombosis. Annals of Surgery 178: 108–112 (1973).
Medical Research Council: Report of the steering committee of a trial sponsored by the Medical Research Council: Effect of aspirin on postoperative venous thrombosis. Lancet 2: 441–444 (1972).
Meyer, D.; Jenkins, C.S.P.; Dreyfus, M. and Larrieu, M.-J.: Experimental model for von Willebrand’s disease. Nature 243: 293–294 (1973).
Michal, F.: D-receptor for serotonin on blood platelets. Nature 227: 1253–1254(1969).
Michal, F.; Bom, G.V.R. and Juengjarden, K.: Platelet receptors; Caen Platelet Aggregation, p. 147–153 (Masson et Cie, Paris 1971).
Michal, F. and Penglis, F.: Inhibition of serotonin-induced platelet aggregation in relation to thrombus production. Journal of Pharmacology and Experimental Therapeutics 166: 276–284 (1969).
Mielke, C.H.; Ramos, J.C. and Britten, A.F.H.: Aspirin as an antiplatelet agent: Template bleeding time as a monitor of therapy. American Journal of Clinical Pathology 59: 236–242 (1973).
Mills, D.C.: Drugs that effect platelet behaviour; in O’Brien Platelet Disorders, Clinics in Haematology, Vol. 1, p. 295–305 (1972).
Mills, D.C.B.; Robb, I.A. and Roberts, G.C.K.: The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation. Journal of Physiology (London) 195: 715–729 (1968).
Mills, D.C.B. and Roberts, G.C.K.: Membrane active drugs and the aggregation of human blood platelets. Nature 213: 35–38 (1967a).
Mills, D.C.B. and Roberts, G.C.K.: Effects of adrenaline on human blood platelets. Journal of Physiology 193: 443–453 (1967b).
Mills, D.C.B. and Smith, J.B.: The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3′: 5′-cyclic monophosphate in platelets. Biochemical Journal 121: 185–196 (1971).
Minsker, D.H.; Jordon, P.T. and MacMillan, A.: Inhibition of platelet aggregation by cyproheptadine;in Sherry and Scriabine Platelets and Thrombosis,p. 161–176 (University Park Press, Baltimore 1974).
Mitchell, J.R.A. and Schwartz, C.J.: Arterial Disease (Blackwell, Oxford 1965).
Mitchell, H.C. and Williams, M.A.: Effect of estrogens and a progestogen on platelet adhesiveness and aggregation in rabbits. Journal of Laboratory and Clinical Medicine 83: 79–89 (1974).
Mitchell, J.R.A. and Sharp, A.A.: Platelet clumping in vitro. British Journal of Haematology 10: 78–93 (1964).
Moncada, S.; Ferreira, S.H. and Vane, J.R.: Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature 246: 217–219 (1973).
Moolten, S.E.; Vroman, L.; Vroman, G.M.S. and Goodman, B.: Role of blood platelets in thromboembolism. Archives of Internal Medicine 84: 667–710 (1949).
Moore, S.: The relation of superficial cortical scars of the kidney to aortic atherosclerosis. Journal of Pathological Bacteriology 88: 471–478 (1964).
Moschos, C.B.; Lahiri, K.; Lyons, M.; Weisse, A.B.; Oldewurtel, H.A. and Regan, T.J.: Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery: Effect of aspirin, dipyridamole and thrombolysis. American Heart Journal 56: 61–86 (1973).
Movat, H.Z. and Di Lorenzo, N.L.: Activation of the plasma kinin system by antigen-antibody aggregates. I. Generation of permeability factor in guinea pig serum. Laboratory Investigation 19: 187–200 (1968).
Muir, H.M. and Mustard, J.F.: Enhancement of platelet aggregation by glycosaminglycans (mucopolysaccharides). In ‘Le rôle de la paroi artérielle dans l’athérogénèse’, Centre national de la recherche scientifique 169: 589–596 (1968).
Mundall, J.; Quintero, P.; von Kaulla, K.; Austin, J. and Harmon, R.: Transient monocular blindness and increased platelet aggregability treated with aspirin. A case report. Neurology 22: 280–285 (1972).
Murakami, M.; Odake, K.; Takase, M. and Yoshino, K.: Potentiating effect of adenosine on other inhibitors of platelet aggregation. Thrombosis et Diathesis Haemorrhagica 27: 252–262 (1972).
Mürer, E.H.: Release reaction and energy metabolism in blood platelets with special reference to the burst in oxygen uptake. Biochimica et Biophysica Acta 162: 320–326 (1968).
Mürer, E.H.: Compounds known to affect the cyclic adenosine monophosphate level in blood platelets: Effect on thrombin-induced clot retraction and platelet release. Biochimica et Biophysica Acta 257: 310–315 (1971).
Mürer, E.H.; Hellem, A.J. and Rozenberg, M.C.: Energy metabolism and platelet function. Scandinavian Journal of Clinical and Laboratory Investigation 19: 280–282 (1967).
Murphy, E.A. and Mustard, J.F.: Coagulation tests and platelet economy in atherosclerotic and control subjects. Circulation 25: 114–125 (1962).
Murphy, E.A. and Mustard, J.F.: Tobacco and thrombosis. American Journal of Public Health 56: 1061–1073 (1966).
Mustard, J.F.; Evans, G.; Packham, M.A. and Nishizawa, E.E.: The platelet in intravascular immunological reactions; in Movat Cellular and Humoral Mechanisms in Anaphylaxis and Allergy, p. 151–163 (Karger, Basel 1969).
Mustard, J.F.; Kinlough-Rathbone, R.L.; Jenkins, C.S.P. and Packham, M.A.: Modification of platelet function. Annals of the New York Academy of Sciences 201: 343–359 (1972b).
Mustard, J.F. and Murphy, E.A.: Effect of smoking on blood coagulation and platelet survival in man. British Medical Journal 1: 846–849 (1963a).
Mustard, J.F. and Murphy, E.A.: Blood platelet economy during moderate and intensive heparin therapy. Blood 22: 1–8 (1963b).
Mustard, J.F; Murphy, E.A.; Downie, H.G. and Rowsell, H.C.: Heparin and thrombus formation: Early suppression and late enhancement. British Journal of Haematology 9: 548–551 (1963).
Mustard, J.F; Murphy, E.A.; Robinson, G.A.; Rowsell, H.C.; Ozge, A.H. and Crookston, J.H.: Blood platelet survival. Thrombosis et Diathesis Haemorrhagica 75 (Suppl.): 245–275 (1964).
Mustard, J.F. and Packham, M.A.: Factors influencing platelet function: Adhesion, release, and aggregation. Pharmacological Reviews 22: 97–187 (1970).
Mustard, J.F.; Perry, D.W.; Ardlie, N.G. and Packham, M.A.: Preparation of suspensions of washed platelets from humans. British Journal of Haematology 22: 193–204 (1972a).
Mustard, J.F; Rowsell, H.C.; Lotz, F.; Hegardt, B. and Murphy, E.A.: The effect of adenine nucleotides on thrombus formation, platelet count and blood coagulation. Experimental and Molecular Pathology 5: 43–60 (1966).
Mustard, J.F; Rowsell, H.C.; Smythe, H.A.; Senyi, A. and Murphy, E.A.: The effect of sulfinpyrazone on platelet economy and thrombus formation in rabbits. Blood 29: 859–866 (1967).
Nachman, R.L.: Platelet proteins. Seminars in Hematology 5: 18–31(1968).
Nachman, R.L.; Marcus, A.J. and Zucker-Franklin, D: Immunological studies of protein associated with subcellular fractions of normal human platelets. J. Lab. clin. Med. 69: 651–658 (1967).
Nachman, R.L.; Weksler, B. and Ferris, B.: Increased vascular permeability produced by human platelet granule cationic extract. Journal of Clinical Investigation 49: 274–281 (1970).
Nachman, R.L.; Weksler, B. and Ferris, B.: Characterization of human platelet vascular permeabilityenhancing activity. Journal of Clinical Investigation 57: 549–556 (1972).
Nemerson, Y. and Pitlick, F.A.: The tissue factor pathway of blood coagulation; in Spaet Progress in Hemostasis and Thrombosis, Vol. 1, p. 1–37 (Grune and Stratton, New York 1972).
Nicolaides, A.N.; Desai, S.; Douglas, J.N.; Fourides, G.; Dupont, P.A.; Lewis, J.D.; Dodsworth, H.; Luck, R.J. and Jamieson, C.W.: Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet 2: 890–893 (1972).
Niewiarowski, S.; Gurewich, V.; Senyi, A.F. and Mustard, J.F.: The effect of fibrinolysis on platelet function. Thrombosis et Diathesis Haemorrhagica 47 (Suppl.): 99–111 (1971).
Niewiarowski, S.; Poplawski, A.; Lipinski, B. and Farbiszewski, R.: The release of platelet clotting factors during aggregation and viscous metamorphosis; in Platelets in Haemostasis. Experimental Biology and Medicine 3: 121–128 (1968).
Niewiarowski, S.; Regoeczi, E.; Stewart, G.J.; Senyi, A. and Mustard, J.F.: Platelet interaction with polymerizing fibrin. Journal of Clinical Investigation 51: 685–700(1972).
Niewiarowski, S.; Senyi, A.F. and Gillies, P.: Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis. Journal of Clinical Investigation 52: 1647–1659 (1973).
Niewiarowski, S.; Stuart, R.K. and Thomas, D.P.: Activation of intravascular coagulation by collagen. Proceedings of the Society for Experimental Biology and Medicine 123: 196–200 (1966).
Niewiarowski, S. and Thomas, D.P.: Platelet aggregation by ADP and thrombin. Nature 272: 1544–1547 (1966).
Nishizawa, E.E.; Wynalda, D.J.; Suydam, D.E. and Molony, B.A.: Flurbiprofen, a new potent inhibitor of platelet aggregation. Thrombosis Research 3: 577–588 (1973).
Novak, E.; Sekhar, N.C.; Dunham, N.W. and Coleman, L.L.: A comparative study of the effect of lung and gut heparins on platelet aggregation and protamine neutralization in man. Clinical Medicine 79: 22–27 (1972).
O’Brien, J.R.: The adhesiveness of native platelets and its prevention. Journal of Clinical Pathology 14: 140–149 (1961).
O’Brien, J.R.: Platelet aggregation. Part I. Some effects of the adenosine phosphates, thrombin and cocaine upon platelet adhesiveness. Journal of Clinical Pathology 15: 446–452 (1962).
O’Brien, J.R.: Some effects of adrenaline and anti-adrenaline compounds on platelets in vitro and in vivo. Nature 200: 763–764 (1963).
O’Brien, J.R.: A comparison of platelet aggregation produced by seven compounds and a comparison of their inhibitors. Journal of Clinical Pathology 17: 275–281 (1964).
O’Brien, J.R.: Changes in platelet membranes possibly associated with platelet stickiness. Nature 272: 1057–1058 (1966).
O’Brien, J.R.: Effects of salicylates on human platelets. Lancet 1: 779–783 (1968a).
O’Brien, J.R.: Effect of anti-inflammatory agents on platelets. Lancet 1: 894–895 (1968b).
O’Brien, J.R.: Platelet membrane mucopolysaccharides: Some relevant observations. Annals of the New York Academy of Sciences 201: 316–328 (1972).
O’Brien, J.R.; Etherington, M. and Jamieson, S.: Heparin-induced platelet release and refractory platelets. Lancet 2: 233–234(1972).
O’Brien, J.R.; Finch, W. and Clark, E.: A comparison of an effect of different anti-inflammatory drugs on human platelets. Journal of Clinical Pathology 23: 522–525 (1970).
O’Brien, J.R. and Heywood, J.B.: Effect of aggregating agents and their inhibitors on the mean platelet shape. Journal of Clinical Pathology 19: 148–153 (1966a).
O’Brien, J.R. and Heywood, J.B.: A comparison of platelet stickiness tests during an Atromid-S trial. Thrombosis et Diathesis Haemorrhagica 16: 768–777 (1966b).
O’Brien, J.R.; Shoobridge, S.M. and Finch, W.J.: Comparison of the effect of heparin and citrate on platelet aggregation. Journal of Clinical Pathology 22: 28–31 (1969).
Okonkwo, P. and Sise, H.S.: Effect of aspirin in vivo and in vitro on plasma cofactors of platelet aggregation. Thrombosis et Diathesis Haemorrhagica 25: 279–287 (1971).
Oliver, M.F.: Ischaemic heart disease: A secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians. British Medical Journal 4: 775–784 (1971).
Olson, J.D.; Fass, D.N.; Bowie, E.J.W. and Mann, K.G.: Ristocetin-induced aggregation of gel-filtered platelets. A study of von Willebrand’s disease and the effect of aspirin. Thrombosis Research 3: 501–514 (1973).
O’Reilly, R.A. and Aggeler, P.M.: Determinants of the response to oral anticoagulant drugs in man. Pharmacological Reviews 22: 35–96 (1970).
Paasonen, M.K.: Platelet 5-hydroxytryptamine as a model in pharmacology. Annales Mediciniae Experimentalis et Biologiae Fenniae 46: 416–422 (1968).
Packham, M.A.; Ardlie, N.G. and Mustard, J.F.: Effect of adenine compounds on platelet aggregation. American Journal of Physiology 217: 1009–1017 (1969a).
Packham, M.A.; Evans, G.; Glynn, M.F. and Mustard, J.F.: The effect of plasma proteins on the interaction of platelets with glass surfaces. Journal of Laboratory and Clinical Medicine 73: 686–697 (1969b).
Packham, M.A. and Guccione, M.A.: Inhibition of platelet responses to synergistic effects of collagen and ADP (abstract). Federation Proceedings 32: 844 (1973a).
Packham, M.A. and Guccione, M.A.: Reactions of polylysine with platelets in plasma and in suspensions of washed platelets. Proceedings of the Fourth International Congress on Thrombosis and Haemostasis, Vienna, p. 177 (1973b).
Packham, M.A.; Guccione, M.A.; Chang, P.-L. and Mustard, J.F.: Platelet aggregation and release: Effects of low concentrations of thrombin or collagen. American Journal of Physiology 225: 38–47 (1973).
Packham, M.A. and Mustard, J.F.: The effect of pyrazole compounds on thrombin-induced platelet aggregation. Proceedings of the Society for Experimental Biology and Medicine 130: 72–75 (1969).
Packham, M.A. and Mustard, J.F.: Drug-induced alteration of platelet function; in Baldini and Ebbe Platelets: Production, Function, Transfusion and and Storage, p. 265–275 (G une and Stratton,New York 1974).
Packham, M.A.; Nishizawa, E.E. and Mustard, J.F.: Response of platelets to tissue injury. Biochemical Pharmacology (Suppl): 171–184 (1968).
Packham, M.A.; Warrior, E.S.; Glynn, M.F; Senyi, A.S. and Mustard, J.F.: Alteration of the response of platelets to surface stimuli by pyrazole compounds. J. exp. Med. 126: 171–188 (1967).
Paterson, J.C.: The pathology of venous thrombi; in Sherry, Brinkhous, Genton and Stengle Thrombosis, p. 321–331 (National Academy of Sciences, Washington, D.C. 1969).
Peter, A.; Regan. T.J.; Jesrani, M.U. and Moschos, C.B.: Effect of aspirin on experimentally induced coronary thrombosis. Clinical Research 18: 669 (1970).
Peterson, J. and Zucker, M.B.: The effect of adenosine monophosphate, arcaine and anti-inflammatory agents on thrombosis and platelet function in rabbits. Thrombosis et Diathesis Haemorrhagica 25: 148–158 (1970).
Pfueller, S.L. and Lüscher, E.F.: The effects of immune complexes on blood platelets and their relationship to complement activation. Immunochemistry 9: 1151–1165 (1972).
Philp, R.B. and Lemieux, V.: Comparison of some effects of dipyridamole and adenosine on thrombus formation, platelet adhesiveness and blood pressure in rabbits and rats. Nature 218: 1072–1074 (1968).
Pineo, G.; Kaegi, A.; Shimizu, A.; Trivedi, H. and Hirsh, J.: The prevention of arterio-venous shunt thrombosis by sulfinpyrazone. Proceedings of the Fourth International Congress on Thrombosis and Haemostasis, Vienna, p. 134(1973).
Pitney, W.R. and Potter, M.: Retention of platelets by glass bead filters. Journal of Clinical Pathology 20: 710–716(1967).
Pletscher, A.: Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. British Journal of Pharmacology and Chemotherapy 32: 1–16 (1968).
Poller, L.; Thomson, J.M.; Tabiowo, A. and Priest, CM.: Progesterone, oral contraception and blood coagulation. British Medical Journal 1: 554–556 (1969).
Poplawski, A.: The effect of angiotensin II on the platelet aggregation induced by adenosine-diphosphate, epinephrine and thrombin. Experientia 26: 86 (1970).
Puszkin, E. and Zucker, M.B.: Enhancement of platelet and muscle actomyosin ATPase activity and superprecipitation by the tumour-promotor 12-O-tetradecanoyl-phorbol-13-acetate (PMA). Nature New Biology 245: 277–280 (1973).
Quick, A.J.: Salicylates and bleeding: The aspirin tolerance test. American Journal of the Medical Sciences 252: 265–269 (1966).
Rattazzi, L.; Haimov, M.N.; Glabman, S.; Papatestas, A.; Gelernt, IM. and Burrows, L.: Role of the platelet in the obliterative vascular transplant rejection phenomenon. Surgical Forum 21: 241–243 (1970).
Reimers, HJ.; Packham, M.A.; Kinlough-Rathbone, R.L. and Mustard, J.F.: Effect of repeated treatment of rabbit platelets with low concentrations of thrombin on their function, metabolism and survival. British Journal of Haematology 25: 675–689 (1973).
Renaud, S. and Godu, J.: Thrombosis prevention by acetylsalicylic acid in hyperlipemic rats. Canadian Medical Association Journal 103: 1037–1040 (1970).
Rittenhouse, E.A.; Hessel, E.A.; Ito, C.S. and Merendino, K.A.: Effect of dipyridamole on microaggregate formation in the pump oxygenator. Annals of Surgery 175: 1–9(1972).
Robbins, S.L.; Berger, R.L.; Suda, Y. and Ryan, T.J.: Myocardial infarction produced by temporary microcoronary occlusion. Circulation 40 (Suppl. 3): 171 (1969).
Roberts, W.C and Buja, L.M.: The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction: A study of 107 necropsy patients. American Journal of Medicine 52: 425–443 (1972).
Robinson, R. W. and Le Beau, R.J.: Platelet adhesiveness and aggregation with chlorophenoxyisobutyric ester. American Journal of Medical Sciences 253: 106–112(1967).
Robison, G.A.; Arnold, A. and Hartmann, R.C.: Divergent effects of epinephrine and prostaglandin E1 on the level of cyclic AMP in human blood platelets. Pharmacological Research Communications 1: 325–332 (1969).
Rosenberg, F.J.; Gimber-Phillips, P.E.; Groblewski, G.E.; Davison, C.; Phillips, D.K.; Goralnick, S.J. and Cahill, E.D.: Acetylsalicylic acid: Inhibition of platelet aggregation in the rabbit. Journal of Pharmacology and Experimental Therapeutics 179: 410–418 (1971).
Rossi, E.C. and Levin, N.W.: Inhibition of ADP-induced platelet aggregation by furosemide. Journal of Laboratory and Clinical Medicine 81: 140–147 (1973a).
Rossi, E.C. and Levin, N.W.: Inhibition of primary ADP-induced platelet aggregation in normal subjects after administration of nitrofurantoin (Furadantin). Journal of Clinical Investigation 52: 2457–2467 (1973b).
Rowsell, H.C.; Glynn, M.F.; Mustard, J.F. and Murphy, E.A.: Effect of heparin on platelet economy in dogs. American Journal of Physiology 213: 915–922 (1967).
Rowland, M. and Riegelman, S.: Pharmacokinetics of acetylsalicylic acid and salicylic acid after intravenous administration in man. Journal of Pharmaceutical Sciences 57: 1313–1319 (1968).
Rozenberg, M.C. and Holmsen, H.: Adenine nucleotide metabolism of blood platelets. IV. Platelet aggregation response to exogenous ATP and ADP. Bio-chimica et Biophysica Acta 157: 280–288 (1968).
Rozenberg, M.C. and Walker, C.M.: The effect of pyrimidine compounds on the potentiation of adenosine inhibition of aggregation, on adenosine phosphorylation and phospodiesterase activity of blood platelets. British Journal of Haematology 24: 409–418 (1973).
Russell, R.W.: Observations on the retinal blood-vessels in monocular blindness. Lancet 2: 1422–1428 (1961).
Ry>sánek, K.; König, J.; >Spánková, H. and Mlejnková, M.: Effect of tricyclic antidepressants on phosphodiesterase. Correlation between aggregability and thrombocyte metabolism. Activitas Nervosa Superior (Praha) 15: 126–127 (1973).
Ry>sánek, R.; Svehla, C; >Spánková, H and Mlejnková, M.: The effect of tricyclic antidepressive drugs on adrenaline and adenosine diphosphate induced platelet aggregation. Journal of Pharmacy and Pharmacology 18: 161–617 (1966).
Sahud, M.A. and Cohen, R.J.: Aspirin-induced prolongation of the Ivy bleeding time. Its diagnostic usefulness. California Medicine 115: 10–13 (1971).
Salzman, E.W.: The limitation of heparin therapy after arterial reconstruction. Surgery 57: 131–138 (1965).
Salzman, E.W.: Nonthrombogenic surfaces: Critical review. Blood 38: 509–523 (1971).
Salzman, E.W.: Cyclic AMP and platelet function. New England Journal of Medicine 286: 358–363 (1972).
Salzman, E.; Harris, W.H. and De Sanctis, R.W.: Reduction in venous thromboembolism by agents affecting platelet function. New England Journal of Medicine 284: 1287–1292(1971).
Salzman, E.W. and Levine, L.: Cyclic 3′, 5′-adenosine monophosphate in human blood platelets. II. Effect of N6-2′-o-dibutyryl cyclic 3′, 5′-adenosine monophosphate on platelet function. Journal of Clinical Investigation 50: 131–141 (1971).
Sanbar, S.S.; Zweifler, A.J. and Smet, G.: In vivo and in vitro effects of polyvinyl-pyrrolidone on platelet adhesiveness in human blood. Lancet 2: 917–919 (1967).
Sanderson, J.H. and Delamore, I.W.: Changes in platelet thrombotic tendency during oral contraception. Journal of Obstetrics and Gynaecology of the British Commonwealth 80: 639–643 (1973).
Sano, T. and Yokoyama, M.: Effect of pyridinocarbamate on platelet aggregation. American Journal of the Medical Sciences 262: 205–209 (1971).
Schneider, W.; Kubier, W. and Gross, R.: Induction of blood platelet aggregation by cationic polypeptides. Thrombosis et Diathesis Haemorrhagica 19: 307 (1968).
Schoene, N.W.; Dutky, R.C. and Iacono, J.M.: Biosynthesis of prostaglandin E2 in human blood platelets from l-14 C-arachidonic acid (abstract). Circulation 46 (Suppl. 2): 32 (1972).
Sharma, H.M.; Moore, S.; Merrick, H. W. and Smith, M.R.: Platelets in early hyperacute allograft rejection in kidneys and their modification by sulfinpyrazone (Anturan) therapy. American Journal of Pathology 66: 445–454 (1972).
Sharma, H.M.; Rosensweig, J.; Chatterjee, S.; Moore, S. and de Champlain, M.-L.: Platelets in hyperacute rejection of heterotopic cardiac allografts in presensitized dogs. American Journal of Pathology 70: 155–174 (1973).
Sharnoff, J.G. and De Blasio, G.: Prevention of fatal postoperative thromboembolism by heparin prophylaxis. Lancet 2: 1006–1007 (1970).
Shepro, D; Belamarich, F.A.; Robblee, L. and Chao, F: Antimotility effect of cytochalasin B observed in mammalian clot retraction. Journal of Cell Biology 47: 544–547 (1970).
Shimamoto, T. and Atsumi, T.: Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger’s disease): A preliminary report on the treatment of human atherosclerosis. Japanese Heart Journal 6: 407–415 (1965).
Shimamoto, T.; Numano, F. and Fujita, T.: Artherosclerosis — inhibiting effect of an antibradykinin agent, pyridinolcarbamate. American Heart Journal 71: 216–227 (1966).
Shio, H.; Plasse, A.M. and Ramwell, P. W.: Platelet swelling and prostaglandins. Microvascular Research 2: 294–301 (1970).
Shio, H. and Ramwell, P.W.: Effect of prostaglandin E2 and aspirin on the secondary aggregation of human platelets. Nature New Biology 236: 45–46 (1972).
Silverman, J.L. and Wurzel, H.A.: The comparative effects of glyceryl guaiacolate and adenosine on the inhibition of ADP-induced platelet aggregation. American Journal of the Medical Sciences 254: 491–498 (1967).
Silverman, J.L. and Wurzel, H.A.: The effect of glyceryl guaiacolate on platelet function and other coagulation factors in vivo. American Journal of Clinical Pathology 57: 35–40 (1969).
Sinapius, D.: Häufigkeit und morphologie der coronarthrombose und ihre beziehungen zur antithrombotischen und fibrinolytischen behandlung. Klinische Wochenschrift 43: 37–43 (1965).
Sixma, J.J. and Trieschnigg, A.M.C.: Inhibition of the function of human blood platelets in vitro by VK 744. Scandinavian Journal of Haematology 8: 417–424 (1971).
Slater, S.D.; Turpie, A.G.G.; Douglas, A.S. and McNicol, G.P.: Effect in vitro on platelet function of two compounds developed from the pyrimidopyrimidines. Journal of Clinical Pathology 25: 427–432 (1972).
Smith, J.B.; Ingerman, C; Kocsis, J.J. and Silver, M.J.: Formation of prostaglandins during the aggregation of human blood platelets. Journal of Clinical Investigation 52: 965–969 (1973).
Smith, J.B.; Silver, M.J.; Ingerman, C.M. and Kocsis, J.J.: Prostaglandin D2 inhibits the aggregation of human platelets. Thrombosis Research (in press) (1974).
Smith, J.B. and Willis, A.L.: Aspirin selectively inhibits prostaglandin production in human platelets. Nature New Biology 231: 235–237 (1971).
Smythe, H.A.; Ogryzlo, M.A.; Murphy, E.A. and Mustard, J.F.: The effect of sulfinpyrazone (Anturan) on platelet economy and blood coagulation in man. Canadian Medical Association Journal 92: 818–821 (1965).
Solum, N.O.: Aggregation of human platelets by bovine platelet fibrinogen. Scandinavian Journal of Haematology 5: 474–485 (1968).
Solum, N.O.; Rigollot, C.; Budzyński, A.Z. and Marder, V.J.: A quantitative evaluation of the inhibition of platelet aggregation by low molecular weight degradation products of fibrinogen. British Journal of Haematology 24: 419–434 (1973).
Spaet, T.H. and Lejnieks, I.: A technique for estimation of platelet-collagen adhesion. Proceedings of the Society for Experimental Biology and Medicine 132: 1038–1041 (1969).
Spaet, T.H. and Zucker, M.B.: Mechanism of platelet plug formation and role of adenosine diphosphate. Amer. J. Physiol. 206: 1267–1274 (1964).
Spain, D.M. and Bradess, V.A.: Relationship of coronary thrombosis to coronary atherosclerosis and ischemic heart disease. American Journal of Medical Sciences 240: 701–707 (1960).
Stornier, J.; Pick, R.; Katz, L.N.; Pick, A.; Kaplan, B.M.; Berkson, D.M. and Century, D.: Effectiveness of estrogens for therapy of myocardial infarction in middle-aged men. Journal of the American Medical Association 183: 632–638 (1963).
Steele, P.P.; Weily, H.S. and Genton, E.: Platelet survival and adhesiveness in recurrent venous thrombosis. New Engl. J. Med. 288: 1148–1152 (1973).
Stemerman, M.B.: Thrombogenesis of the rabbit arterial plaque. American Journal of Pathology 73: 7–26 (1973).
Stemerman, M.B.; Baumgartner, H.R. and Spaet, T.H.: The subendothelial microfibril and platelet adhesion. Laboratory Investigation 24: 179–186 (1971).
Stuart, M.J.; Murphy, S.; Oski, FA.; Evans, A.E.; Donaldson, M.H. and Gardner, F.H.: Platelet function in recipients of platelets from donors ingesting aspirin. New England Journal of Medicine 287: 1105–1109 (1972).
Sullivan, J.M.; Harken, D.E. and Gorlin, R.: Pharmacologic control of thromboembolic complications of cardiac-valve replacement. New England Journal of Medicine 284: 1391–1394 (1971).
Sutor, A.H.; Bowie, E.J.W. and Owen, CA.: Effect of aspirin, sodium salicylate, and acetaminophen on bleeding. Mayo Clinic Proceedings 46: 178–181 (1971).
Taylor, R.E.; Stitt, E.S.; Robison, G.A. and Hartmann, R.C.: Characterization of prostaglandin-cyclic AMP interactions in human blood platelets. Blood 42: 994 (1973).
Thomas, D.P.: The role of platelet catecholamines in the aggregation of platelets by collagen and thrombin; in Platelets in Haemostasis. Experimental Biology and Medicine 3: 129–134 (1968).
Thomson, C.; Forbes, CD. and Prentice, C.R.M.: Relationship of factor VIII to ristocetin-induced platelet aggregation; effect of heterologous and acquired factor VIII antibodies. Thrombosis Research 3: 363–373 (1973).
Tranzer, J.P. and Baumgartner, H.R.: Filling gaps in the vascular endothelium with blood platelets. Nature 216: 1126–1128 (1967).
Tsai, C-C.; Taichman, N.S.; Pulver, W.H. and Schönbaum, E.: Heterophile and tissue injury III. A role for platelets in the development of lethal vascular injury during Forssman shock in guinea pigs. American Journal of Pathology 72: 179–200 (1973).
Ts’ao, C.-K.: Platelet aggregation by ristocetin in EDTA plasma: Extensive clumping with high concentrations of EDTA. Haemostasis 1: 315–319 (1972/73). Turpie, A.G.G.; Chernesky, M.A.; Larke, R.P.B.; Moore, S.; Regoeczi, E. and Mustard, J.F.: Thrombocytopenia and vasculitis induced in rabbits by Newcastle disease virus. Proceedings of the Third Congress of the International Society on Thrombosis and Haemostasis, Washington, D.C., p. 344 (1972).
Turpie, A.G.G.; Chernesky, M.A.; Larke, R.P.B.; Packham, M.A. and Mustard, J.F.: Effect of Newcastle disease virus on human or rabbit platelets. Laboratory Investigation 28: 575–583 (1973).
Turpie, A.G.G. and Stewart, I.O.: The effect of bacteria on platelet aggregation and the platelet release reaction (abstract). Federation Proceedings 32: 835 (1973).
Veda, I.: The effects of volatile general anesthetics on adenosine diphosphate-induced platelet aggregation. Anaesthesiology 34: 405–408 (1971).
United States Bureau of the Census: Statistical Abstract of the United States, Washington, D.C., p. 58 (1970).
Vainer, H.; Jeanneau, C.; Booyse, F.M. and Wassermann, N.: Platelet-polyelectrolytes interactions. Some properties of the polylysine induced platelet aggregation. Possible correlations with the surface located contractile protein. In Caen Platelet Aggregation, p. 137–146 (Masson et Cie, Paris 1971).
Valdorf-Hansen, J.F. and Zucker, M.B.: Effect of temperature and inhibitors on serotonin 14C release from human platelets. American Journal of Physiology 220: 105–111 (1971).
Vermylen, J.; de Gaetano, G. and Verstraete, M.: Platelets and thrombosis; in Poller Recent Advances in Thrombosis, p.113–150 (Churchill Livingstone, London 1973).
Vermylen, J.; Dotremont, G.; de Gaetano, G.; Donati, M.B. and Michielsen, P.: Indomethacin and urinary excretion of fibrinogen-like material in proliferative glomerulonephritis. Revue Européene d’Etudes Cliniques et Biologiques (Paris) 15: 979–984 (1970).
Vessey, M.P.; and Doll, R.: Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. British Medical Journal 2: 651–657 (1969).
Veterans Administration Co-operative Urological Research Group. Treatment and survival of patients with cancer of the prostate. Surgery, Gynecology and Obstetrics 124: 1011–1017 (1967).
Vigdahl, R.L.; Mongin, J. and Marquis, N.R.: Platelet aggregation IV. Platelet phosphodiesterase and its inhibition by vasodilators. Biochemical and Biophysical Research Communications 42: 1088–1094(1971).
Waisbren, B.A.; Evani, S.V. and Ziebert, A.P.: Carbenicillin and bleeding. Journal of the American Medical Association 217: 1243 (1971).
Walsh, P.N.: The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII. British Journal of Haematology 22: 393–405 (1972a).
Walsh, P.N.: The role of platelets in the contact phase of blood coagulation. British Journal of Haematology 22: 237–254 (1972b).
Walsh, P.N. and Biggs, R.: The role of platelets in intrinsic factor-Xa formation. British Journal of Haematology 22: 743–760 (1972).
Weber, W.; Wolff, U. and Bromig, G.: Postoperative thromboembolieprophylaxe mit clofarit. Therapeutische Berichte 45: 229 (1971).
Weily, H.S. and Genton, E.: Altered platelet function in patients with prosthetic mitral valves. Effects of sulfinpyrazone therapy. Circulation 42: 967–972 (1970).
Weiss, H.J.: The effect of clinical dextran on platelet aggregation, adhesion, and ADP release in man: In vivo and in vitro studies. Journal of Laboratory and Clinical Medicine 69: 37–46 (1967).
Weiss, H.J.: The pharmacology of platelet inhibition; in Spaet Progress in Haemostasis and Thrombosis, Vol. 1, p. 199–231 (Grune and Stratton, New York 1972).
Weiss, HJ.; Aledort, L.M. and Kochwa, S.: The effect of salicylates on the hemostatic properties of platelets in man. J. clin. Invest. 47: 2169–2180 (1968).
Weiss, HJ.; Hoyer, L.W.; Rickles, F.R.; Varma, A. and Rogers, J.: Quantitative assay of a plasma factor deficient in von Willebrand’s disease, that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. Journal of Clinical Investigation 52: 2708–2716 (1973a).
Weiss, HJ. and Rogers, J.: (unpublished data) cited by Weiss, H.J. (1972).
Weiss, H.J.; Rogers, J. and Brand, H: Further studies on the von Willebrand factor (factor VIII) — Ristocetin-induced platelet aggregation. Blood 40: 939a (1973b).
Weksler, B.B. and Coupai, C.E.: Platelet-dependent generation of chemotactic activity in serum. Journal of Experimental Medicine 137: 1419–1430 (1973).
Weksler, B.B. and Nachman, R.L.: Rabbit platelet bactericidal protein. Journal of Experimental Medicine 134: 1114–1130 (1971).
Werle, E. and Schievelbein, H.: Activity of nicotine and inactivity of kallikrein and kallidin in aggregation of blood platelets. Nature 207: 871–872 (1965).
Wessler, S.; Reimer, S.M.; Freiman, D.G. and Thomas, D.P.: Factors involved in the initiation of thrombosis; in MacMillan and Mustard Anticoagulants and Fibrinolysins, p. 108–116 (Macmillan Company of Canada, Toronto 1961).
Wessler, S.; Sheps, S.G.; Gilbert, M. and Sheps, M.C.: Studies in peripheral arterial occlusive disease. HI Acute arterial occlusion. Circulation 17: 512–525 (1958).
Wessler, S. and Yin, E.T.: On the mechanism of thrombosis. Progress in Hematology 6: 201–232 (1969).
Westerholm, B.: Dextran-induced release of 5-hydroxytryptamine from rabbit platelets. Acta Physiologica Scandinavica 67: 236–242 (1966).
White, J.G.: Fine structural alterations induced in platelets by adenosine diphosphate. Blood 31: 604–622 (1968a).
White, J.G.: Effects of colchicine and vinca alkaloids on human platelets. I. Influence on platelet microtubules and contractile function. American Journal of Pathology 53: 281–291 (1968b).
White, J.G.: A biphasic response of platelets to serotonin. Scandinavian Journal of Haematology 7: 145–151 (1970).
White, J.G.: Platelet microtubules and microfilaments: Effects of cytochalasin B on structure and function; in Caen Platelet Aggregation, p. 15–52 (Masson et Cie, Paris 1971a).
White, J.G.: Platelet morphology; in Johnson The Circulating Platelet p. 45–121 (Academic Press, New York 1971b).
White, J.G.: Effects of cationic polypeptides on thrombasthenic and afibrinogenemic blood platelets. American Journal of Pathology 68: 447–458 (1972a).
White, J.G.: Exocytosis of secretory organelles from blood platelets incubated with cationic polypeptides. American Journal of Pathology 69: 41–50 (1972b).
White, J.G.; Goldberg, N.D.; Estensen, R.D.; Haddox, M.K. and Rao, G.H.R.: Rapid increase in platelet cyclic 3′5′ — guanosine monophosphate (cGMP) levels in association with irreversible aggregation, degranulation and secretion. Journal of Clinical Investigation 52: 89a (1973).
Williams, T.J. and Morley, J.: Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 246: 215–217 (1973).
Willis, A.L.: Biosynthesis of prostaglandins E2 and F2α generates labile material which induces platelet aggregation. Proceedings of the Fourth International Congress on Thrombosis and Haemostasis, Vienna, p. 79 (1973).
Wilner, G.D.; Nossel, H.L. and Le Roy, E.C.: Activation of Hageman factor by collagen. Journal of Clinical Investigation 47: 2608–2615 (1968).
Wolfe, S.M. and Shulman, N.R.: Adenyl cyclase activity in human platelets. Biochemical and Biophysical Research Communications 55: 265–272 (1969).
Wolfe, S.M. and Shulman, N.R.: Inhibition of platelet energy production and release reaction by PGE1, theophylline and cAMP. Biochemical and Biophysical Research Communications 41: 128–134 (1970).
Wood, L.: Treatment of atherosclerosis and thrombosis with aspirin. Lancet 2: 532–533 (1972a).
Wood, L.: Aspirin and myocardial infarction. Lancet 2: 1021–1022 (1972b).
Wright, H.P.: The adhesivenss of blood platelets in normal subjects with varying concentrations of anticoagulants. Journal of Pathology and Bacteriology 55: 255–262 (1941).
Yamazaki, H.; Sano, T.; Odakura, T; Takeuchi, K.; Matsumura, T.; Hosaki, S. and Shimamoto, T.: Appearance of thrombogenic tendency induced by adrenaline and its prevention by β-adrenergic blocking agent, nialamide and pyridinolcarbamate. Thrombosis et Diathesis Haemorrhagica 26: 251–263 (1971).
Yamazaki, H.; Sano, T.; Odakura, T.; Takeuchi, K. and Shimamoto, T.: Electrocardiographic and hematological changes by exercise test in coronary patients and pyridinolcarbamate pretreatment. A double-blind crossover trial. American Heart Journal 79: 640–647 (1970).
Yamazaki, H.; Sano, T. and Shimamoto, T.: Enhancement of ADP-induced platelet aggregation by adrenaline and cholesterol and its prevention. Proceedings of the Third Congress of the International Society on Thrombosis and Haemostasis, Washington, D.C., p. 262 (1972).
Yin, E.T.; Giudice, L. and Wessler, S.: Inhibition of activated factor X-induced platelet aggregation: The role of heparin and the plasma inhibitor to activated factor X. Journal of Laboratory and Clinical Medicine 82: 390–398 (1973).
Yin, E.T.; Wessler, S. and Stoll, P.J.: Biological properties of the naturally occurring plasma inhibitor to activated factor X. Journal of Biological Chemistry 246: 3703–3711 (1971).
Youssef, A. and Barkhan, P.: Release of platelet factor 4 by adenosine diphosphate and other platelet aggregating agents. British Medical Journal 1: 746–747 (1968).
Zacharski, L.R.; Walworth, C. and McIntyre, O.R.: Anti-platelet therapy for thrombotic thrombocytopenic purpura. New England Journal of Medicine 285: 408–409 (1971).
Zahavi, J.; Dreyfuss, F.; Kalef. M. and Soferman, N.: Adenosine diphosphate-induced platelet aggregation in healthy women with and without a combined and sequential contraceptive pill. American Journal of Obstetrics and Gynecology 117: 107–113 (1973).
Zekert, F.; Kohn, P. and Vormittag, E.: Prophylaxis of thromboembolic disease in traumatologic patients, a randomized double blind study with acetylsalicylic acid (abstract). Proceedings of the Fourth International Congress on Thrombosis and Haemostasis, Vienna, p. 281 (1973).
Zelikovsky, A.; Urca, I.; Shaklai, M. and de Vries, A.: A clinical trial with pyridinolcarbamate in the treatment of patients with obstructive diseases of the peripheral arteries. Japanese Heart Journal 14: 12–21 (1973).
Zieve, P.D. and Greenough, W.B.: Adenyl cyclase in human platelets: Activity and responsiveness. Biochemical and Biophysical Research Communications 35: 462–466 (1969).
Zieve, P.D. and Solomon, H.M.: Effects of diuretics on the human platelet. American Journal of Physiology 215: 650–654 (1968).
Zucker, M.B.: Platelet agglutination and vasoconstriction as factors in spontaneous hemostasis in normal, thrombocytopenic, heparinized and hypoprothrombinemic rats. American Journal of Physiology 148: 275–288 (1947).
Zucker, M.B.: Unpublished observation quoted in Marcus and Zucker The Physiology of Blood Platelets (Grune and Stratton, New York 1965).
Zucker, M.B.: The platelet release reaction. Canadian Medical Association Journal 108: 445 (1973).
Zucker, M.B. and Jerushalmy, Z.: Studies on platelet shape and aggregation; effect of inhibitors on these and other platelet characteristics; in Johnson and Seegers Physiology of Hemostasis and Thrombosis, p. 249–265 (Thomas, Springfield 1967).
Zucker, M.B. and Peterson, J.: Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proceedings of the Society for Experimental Biology and Medicine 127: 547–551 (1968).
Zucker, M.B. and Peterson, J.: Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets. Journal of Laboratory and Clinical Medicine 76: 66–75 (1970)
Author information
Authors and Affiliations
Additional information
See subject index in each issue for further indexing terms.
Rights and permissions
About this article
Cite this article
Mustard, J.F., Packham, M.A. Platelets, Thrombosis and Drugs. Drugs 9, 19–76 (1975). https://doi.org/10.2165/00003495-197509010-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197509010-00003